Trump's Drug Price Order: A Necessary Step or a Logistical Nightmare?

President Trump's executive order to lower drug prices in the US has sparked a debate about the feasibility and impact of such a policy. The order aims to align US prices with the lowest globally. However, experts like Stacie Dusetzina of Vanderbilt University raise concerns. "The logistical challenge of understanding what prices are paid in other countries has not been solved," she notes. The order involves multiple federal agencies, including the Department of Justice, potentially using antitrust actions. The FDA is also tasked with exploring drug importation from other countries, a process complicated by the fact that Canada, a potential source, is unwilling to participate in drug importation programs with the US. While the initiative could potentially lower costs for some consumers, the complexity and potential hurdles suggest that significant changes are unlikely to occur immediately.